What were the biggest health tech trends in 2025? After a year of conversations with dozens of founders, clinicians, and investors, we're cutting through the noise to reveal what actually changed, where the hype fell flat, and where real momentum is building. We unpack the surprising gap between private equity investment and medical AI, debating whether AI is truly making healthcare faster and cheaper or if the money is flowing elsewhere.
In this special 2025 year-in-review, the HealthTech Remedy hosts - Dr. Tim Showalter, Dr. Paul Gerrard, and Dr. Trevor Royce - step back to connect the dots from a transformative year. We explore the massive theme of AI in healthcare, moving beyond buzzwords to distinguish between generative AI and classification models and how they are practically applied in the clinic today. We challenge the narrative of AI replacing doctors, arguing instead that technology is empowering clinicians with new "superpowers" and cementing the importance of the human element in patient care.
This episode synthesizes a year of insights into the most important health tech trends of 2025. We dive deep into the rise of physician entrepreneurs in health tech, highlighting how clinical leaders are the key to building successful companies that solve real-world workflow problems. We also tackle the foundational, less glamorous, but critical challenges of healthcare data integration and EHR interoperability, discussing how solving these "1980s engineering problems" is finally unlocking modern innovation. From automating healthcare administration nightmares with companies like Infinitus Systems to creating entirely new categories of patient care with Viz.ai, we cover the companies and ideas that challenged our thinking. We discuss the last-mile delivery solutions of Sprinter Health and Hims & Hers, the drug repurposing mission of Every Cure, the paradigm-shifting vision of the Enhanced Games, and key takeaways from the HLTH 2025 conference. Join us as we reflect on the lessons learned and what they mean for the future of healthcare.
Companies Discussed in This Episode:
Introduction
Dr. Tim Showalter: Happy New Year.
Dr. Trevor Royce: Were you guys on the naughty or the nice list this year?
Dr. Tim Showalter: I did get some coal from my mom. I made sure that she—I don't know what I did to get in trouble. Hopefully she's not mad at me.
Dr. Trevor Royce: That's an annual event at the Showalter House, I imagine.
Dr. Tim Showalter: Any fun kids gifts for your crews? Mine are old enough that it's clothes and gift cards or whatever.
Dr. Trevor Royce: One, a hoverboard. You lean forward and it goes. I'm definitely going to break my wrist. And the other are for my four-year-old Hulk smash hands. They're these big padded gloves, and he's just been punching brother in the face. It's fantastic.
Dr. Tim Showalter: That's perfect. How are you, Paul?
Dr. Paul Gerrard: Good Christmas. Somebody got me a giant Snoopy doll. I'm a Snoopy fan, so that was a good present for me. And then I think my kids made out like bandits.
Dr. Tim Showalter: I got an ice cream maker, so when you guys visit, I'll have to impress you. Should we hop in?
Dr. Trevor Royce: Let's do it.
Reflecting on 2025's Key Health Tech Learnings
Dr. Tim Showalter: Welcome to Health Tech Remedy. I'm Tim Showalter.
Dr. Paul Gerrard: And I'm Dr. Paul Gerrard.
Dr. Trevor Royce: And I'm Trevor Royce.
Dr. Tim Showalter: This is a special end of 2025 episode. Instead of featuring a single guest or company, the three of us wanted to step back and reflect on what we've learned from the founders, clinicians, investors, and operators we've had the privilege of speaking with throughout the year.
Dr. Paul Gerrard: We've talked with physician innovators building AI platforms, clinicians stepping into executive and investor roles and just leaders working at the intersection of data, workflow, and real-world clinical impact. And across these conversations, some very clear themes started to emerge.
Dr. Trevor Royce: We've got a holiday special for everybody today. Pretty excited about chatting with you guys. Today's episode is about pulling all those threads of the year together. We'll talk about what actually changed in health tech this year, what surprised us, where the hype maybe didn't hold up, and what we're seeing in the areas we're seeing real momentum as we head into 2026.
Dr. Tim Showalter: I think we'll talk about some consistent themes that emerged, for example, the evolution of AI from promise to practice and real infrastructure and what clinicians and health systems are asking for right now and how health technology can deliver those. And I think hopefully we'll have some fun reflections back onto what we accomplished during the year.
Dr. Paul Gerrard: I think we're going to try to be candid and reflective, not predicting for prediction's sake, but try to talk about the lessons that we've learned.
Dr. Trevor Royce: And close with a bit of a round robin on the guests and companies that we featured, those that challenged our thinking this year, and a clear takeaway for anyone operating at the intersection of healthcare and technology.
Dr. Tim Showalter: All right, let's hop in. Let's talk about the big picture, what we learned in 2025 for health technology and where we think things are right now and where they're headed.
The Big Picture: AI Investment vs. Private Equity in Healthcare
Dr. Paul Gerrard: I'm going to open with something that I think is a little bit provocative. I was just reading a few days ago about investment in, I think this was maybe 2024 because that was the most recent data that we had. But I had read in 2024, there was about $5 billion estimated to be invested in medical AI.
Now, AI is really big. Medical AI is supposed to be this hotspot, $5 billion sounds big. Until you compare it with private equity investment in healthcare practices, which is about $100 billion. What that says to me is in terms of where the money is going, sure, there's a lot of interest in innovation and AI in healthcare, but it's still the tiny place for investment and money in healthcare as compared to other places that you can put money in healthcare.
Dr. Tim Showalter: That's an interesting stat. I'm just trying to think about what to take from that because obviously the investment and the overall, for private equity, I think of more of the traditional healthcare infrastructure investments, the ones we read about, practices being merged, hospitals being bought. I'm wondering if those trends are really at odds because it seems like we've heard a lot this past year about how AI and technology is solving for workflows.
We have consistently heard, 'don't make, I don't need you to make a healthcare better with AI. I need you to make it faster, cheaper.' And I wonder if there might be some connection here where the real beneficiaries of AI may be some of these private equity investments as well.
Dr. Paul Gerrard: I don't have a good reference for where this came from, so I'm not going to be academic here, but I guess this separating out who's a traditional infrastructure player versus AI company, I can imagine is not clean. And maybe some of this innovation is happening in-house in what we'd consider the traditional infrastructure players.
Dr. Trevor Royce: Obviously, a very core theme of it all was artificial intelligence, especially for the large enterprise-level companies. They will at least attempt to build some of this in-house until they realize they can't and then they go elsewhere to find help in whatever problems they're trying to solve. And that's where a lot of the startups that we've spoken to will step in and find their success.
Dr. Tim Showalter: One observation for 2025 is that I think everyone's familiar with some AI in some degree of their workplace functions and are thinking about AI and how to use it to their benefit. I do think this is a year of all of us trying AI in our clinics and in our day-to-day work. And obviously it's just becoming so common. And you have to think that a lot of these investment theses as we enter 2026 will incorporate all the efficiencies gained from new AI-derived technologies.
Defining the Role of AI: Generative vs. Classification and Augmenting Humans
Dr. Paul Gerrard: One thing I've also noticed is we talk about AI, we throw around this word AI, like it's this homogenous thing. And we're guilty of it right now, but AI is a lot of different things. We're all very familiar with the classical prediction and classification AI. AI looks at, say, a number, looks at an image and gives you a number, a probability of something, for example.
And that's one application of AI, but it seems the attention that AI is getting, people tend to be more focused on that generative AI side of things, the large language models. They're two very different applications of AI. And I think one of the things I'm anecdotally noticing when I talk to other clinicians is they're not distinguishing between the two. You use the word AI and their brain immediately goes to transcription assistants, large language models, things that can look at the record, suggest ideas to me, not that more conventional classification and prediction AI, which is actually where a lot of interesting work is happening.
Dr. Tim Showalter: That's true. Everybody forgets about machine learning.
Dr. Trevor Royce: This may be a controversial statement or maybe not. I would love to hear your guys' reaction on this, but a lot of the national dialogue around AI is always about how it will replace humans. And I have to tell you, if I have noticed anything amongst our many discussions now on this podcast, it is that the human in healthcare is not being replaced. There's no question that that role is even more entrenched than ever. And all these tools, I would say almost uniformly, all these tools help the human do their job hopefully better and more efficiently as opposed to actually removing them from the human element of healthcare.
The Rise of Physician Entrepreneurs in Health Tech
Dr. Tim Showalter: I think that's so true, Trevor. And maybe that's a good point to talk about some of the humans we met this year too. I think that is the critical piece, that ultimately healthcare happens between humans. There's physicians and patients and ultimately the tools that are developed and that are successful are going to fit within those workflows and make sure that things are moving forward.
One of the things that I was really impressed by is all the different versions of the stories that we heard about from physician innovators and entrepreneurs this year. We heard a lot of stories about people transitioning from clinical careers into health technology leadership. I'm thinking about our Hims & Hers episode. I'm thinking about [Could not verify with context] and others. And what really resonated with me is that there were so many different versions of these stories.
And ultimately, what was so key is having an experienced clinician leading, operating within a company and moving things forward. And I think that's how you're going to actually get to technologies that improve outcomes overall: you're not going to replace the humans, but you have to give them superpowers.
Dr. Paul Gerrard: That makes a lot of sense. Looking back through our episodes, one of the big things I got out of it is when we look at the companies that are having successes, I guess the way I'd characterize them is they aren't actually AI companies or tool providers. They're really catalysts for change.
They understand, 'hey, here are the problems in healthcare. This is what is needed in the healthcare system. This is how it can be changed in ways that will help people.' And then that's the big thing, and the AI and technology are the implementation details to achieve that. And I think that's why we're seeing you get these clinicians who transition from clinical work to leadership at health technology companies really having success.
Dr. Tim Showalter: That resonates. The AI is not only the technology, but I think we saw some examples where AI is the infrastructure. Thinking about Artisight, for example, where I hadn't really thought about the value of video data and how important that is. And we heard this from Virgo as well, but it really does unlock a higher level of insights.
And obviously, some of these examples are related to patient safety or cutting down on nursing turnovers. But there's also this component of moving towards trust and making sure that payers are paying for health care that actually happens and physicians have some of the negative parts of their job automated, so that there's potentially a world where we're not going through the laborious documentation because the video supports what happened. You can document it that way. It's interesting how it's providing a different infrastructure altogether.
The Foundational Challenge: Healthcare Data Integration and EHR Interoperability
Dr. Paul Gerrard: That's a good point to talk about something else, which is one of the things we heard a lot about was the challenges around connectivity and data integration. A lot of these innovators are building tools that can potentially make things faster or other kinds of great innovations. But then the question is, how do you get the health system to say, 'you can come plug into our IT infrastructure to even get a test run on it.'
And when we talked to a number of the companies, you listen to their first big break and what enabled them to catapult forward was they got that first agreement or two from one or two health systems. And it sounded like that has never been an easy thing to do.
Dr. Tim Showalter: It's not just trust, but it's having a solution that's important enough to advocate for all the IT work that has to be done.
Dr. Trevor Royce: This is maybe not the most exciting topic, but another consistent theme across this was the importance of data standards. And finally, it feels like in medicine, we're reaching a point where we have this incredible technology that can analyze massive amounts of data very quickly through modern AI chips and so forth.
But also you have consistent data standards that are allowing that same language to be spoken across healthcare systems. We saw that a lot, but we talked about that quite a bit with Amy Abernathy on the real world data side, how you're able to integrate into health records and so forth. And that's been such a bugaboo for healthcare technology for so long. And now finally these systems can talk to each other.
Dr. Tim Showalter: In a sense, that's what we heard from Science 37 as well. On the research side is about how challenging thinking through the data infrastructure is and how powerful it can be to streamline and accelerate and unify that across the board.
Dr. Paul Gerrard: None of those really sound like AI challenges. They sound like the kinds of things that engineers were dealing with in the 1980s. We're still struggling with them today.
Dr. Tim Showalter: But I do think their expectation is that technology can move faster. Just a few years ago, I thought EHR interoperability across different platforms seemed to me like an impossible thing to solve. And it does seem like now you're hearing about more solutions being integrated within health systems.
And even from some companies, not examples from shows that we've had this year, but you're reading some press releases about companies rebuilding EHRs from the ground up. I think a lot of us saw the Oracle press release, for example. And it does make you wonder when you hear all these examples about intelligent hospitals and all of the sensors that will be available and everything connected through an Internet of Things, are we getting to a different future for healthcare and how the documentation occurs?
Standout Companies and Surprising Insights from 2025
Trevor, what was the episode or guest or company that surprised you the most in the conversation?
Dr. Trevor Royce: One guest we had that really stuck with me was David Faganbaum with Every Cure. It was such a deeply personal story and so impactful. And then obviously, just following their story, as we've had them—they were one of our earlier guests. They've just continued to do amazing work, get a lot of publicity and he's done a lot of amazing articles and interviews and so forth.
But this idea of having a nonprofit drug company, and I just want them to succeed so bad. And so far, it seems they are. And if they can repurpose these old drugs and help these orphan diseases that otherwise have no hope, that's just a fantastic story. That episode was a lot of fun and it stuck with me on a day-to-day level.
Dr. Tim Showalter: Paul, what about you?
Dr. Paul Gerrard: I think one of the things that really stuck with me was Infinitus Systems—not to be called Infinitus, by the way. Because they're really trying to automate away something that probably shouldn't even exist. There's all this back and forth communication, and healthcare is supposed to be about caring for patients, making patients better. And you get this burgeoning industry of bureaucratic paperwork in healthcare.
My feeling is that for my entire lifetime, the focus on healthcare has been increasing that bureaucratic paperwork without really meaningful improvements for patients. And here you have a company that comes along and is saying, 'okay, great, it's there. It may even have a necessary purpose, but it's not making anybody better. So whatever its purpose, let's see if we can try to automate some of that away with AI so that the healthcare providers can really go back to just focusing on healthcare instead of picking up the phone, trying to get somebody at the insurance company, not available, try again later'—the things that I think everybody hates doing.
Dr. Tim Showalter: That's a great point. I'm going to cheat a little bit and merge two episodes for mine. I think we recorded them around the same time. And there are some connections that I thought were pretty interesting. One was the episode with Sprinter Health. We interviewed [Could not verify with context]. And the other was the episode on Hims & Hers. We interviewed Dr. Patrick Carroll.
And it was interesting to hear both of their stories started off with having a health care career focused on public health. You remember that Dr. Carroll had stories about providing health care within Native American reservations. And Dr. Welch had some perspectives from what are the last mile problems within urban environments?
And it was interesting that they both found themselves within health technology companies. And I do think that both of those companies have very different business models, but ultimately what they're solving are the last mile problems with technology. Sprinter Health is really interesting to have the actual sprinters who are mobile and can help provide care.
And then for the Hims & Hers model, I didn't realize until we had that conversation with Patrick that just how purpose-built Hims & Hers is as an overall, all-encompassing platform, the model for asynchronous care, the systems that are in place, even some of the product development and production of drugs was something I hadn't really thought of. And in talking to them, I think we all learned that a lot of the young patients that they're reaching might not otherwise interact with the healthcare system in the same way. It's a really useful platform for patients to have access to care that they might not otherwise make the time to receive, or there may be some stigma attached to receiving that. And I think it's a really powerful force. Those were the ones that stuck with me throughout the year.
Tackling an Endless Pain Point: Automating Healthcare Administration
Paul, there was a lot on the payment side that we covered too.
Dr. Trevor Royce: But never enough for Paul.
Dr. Tim Showalter: Never enough for Paul.
Dr. Paul Gerrard: That's just a source of endless pain for healthcare providers. It's funny, everybody talks about, 'hey, how do we get this new technology paid for by payers?' But even if you get the payers to theoretically pay for it, you're not just getting paid automatically. You still have to go through the billing process.
And as we learned, the billing process itself can be a bear to deal with due to things like it's not just, 'hey, we put a CPT code on a claim, submit it and get paid.' There's prior authorization for hospital billing, making sure that you captured the right diagnoses to code the claim correctly. That's laborious because it involves abstracting the entire chart. And so, one of the big things is just that very mundane act of correctly billing and getting paid. There's a lot of interest in how can we try to automate that as much as possible to reduce the human time required to do it. And also, I think, probably to increase some of the accuracy on it, too, capturing data that is not otherwise there.
Dr. Tim Showalter: We had a bunch of conversations. We featured Cohere Health, Onco Health, not directly related, but Turquoise Health, focused on price transparency, SmarterDX, of course, the most directly responsive to that. There's clearly a lot there. And I think you're right that on both sides of the transaction, you want to make sure that things are as accurate as possible. And if we can automate that, I think it's a real help for the health care system.
Beyond Efficiency: How AI Is Creating Net-New Healthcare Products
Dr. Trevor Royce: And a lot of different elements of that, on the revenue cycle management side, payer coverage determination, large systems, small systems, and everything in between. It's so, as you know better than anyone, Paul, so incredibly complicated and multilayered that we saw so many very unique tools tackling very different elements of that entire system.
Another thing that's interesting to think about is in broad buckets where AI—because AI obviously was a consistent theme across almost every episode—is making some process better. And that could be reviewing claims, for example, or AI creating an entirely net new product that basically didn't exist before that technology was available. And I think that second bucket is much more rare, but it is increasingly out there.
And I'll give you a shout out, Tim. I think one example is some of what Viz.ai is doing, where some of these tools literally did not exist in healthcare until you were able to, at speed, analyze whatever data modality you have in front of you, whether it's, let's take stroke detection, for example. And that's super cool and a great example of what AI could unlock in the future, today and moving forward.
Dr. Tim Showalter: I think it's a great call. I think Chris Mansi is definitely one of my favorite CEO interviews of the year, for sure. A really inspiring story about his observations as a young neurosurgeon doing a great surgery, but the patient had a bad outcome because she got to the operating room with too many delays. And that core insight about leveraging AI algorithms—and Paul, to get back to your point about machine learning, this is an AI tool that is deep learning enabled, not LLM enabled—but leveraging that powerful and rapid insight to not only deliver the risk prediction based on that scan and correctly identify that patient, but to mobilize the entire care team. I think that's really what Viz's key insight is. And again, it's not just AI, right? It's the care coordination and the overall workflows that's so powerful.
Unlocking Untapped Data: From Endoscopy Footage to Clinical Guidelines
Dr. Trevor Royce: Another cool theme that's become evident at what has set some of these entrepreneurs apart in their success is being able to recognize areas that have an incredible amount of data that was just untapped or inaccessible in some way until this modern world. And we saw that with the endoscopy footage that had been sitting on a shelf and basically underutilized. And then you had a brilliant entrepreneur recognize that this was an untapped resource that could be analyzed in a much better way.
I think we saw that with ASCO, Clifford Hudis, their CEO, these big ASCO guidelines, very complicated documents. Let's build an LLM in collaboration directly with Google Health to have that more accessible and at the fingertips of the clinicians in the clinic. That was pretty cool to see.
Dr. Tim Showalter: That's pretty interesting. I remember Cliff saying during the interview that it's causing them to rethink how frequently they update their guidelines too, because the expectation now is that people are going to want real-time insights. And for those who are not within the oncology space, I guess most people have some experience with periodically updated guidelines. This is usually every two to three years.
But I think now with how quickly things are moving, the expectation is to have more frequently updated guidelines. And I think for ASCO members and for oncologists, it's going to be hugely helpful to have those digitized. And I think that's just the tip of the iceberg. There's more coming.
Dr. Paul Gerrard: Which I think is crazy. NCCN guidelines, I think get updated annually. But you go look at a lot of medical specialties and there's not even a scheduled update cycle. They update the guidelines and then whenever a bunch of people who are affiliated with the relevant guideline body have time to get around to it, they update the guidelines again. Maybe three years away, maybe seven years away, maybe ten years.
Key Company Takeaways from the HLTH 2025 Conference
Dr. Tim Showalter: Maybe we should talk about Health a little bit too—the HLTH conference as podcast co-hosts. And Trevor, you were not able to make it.
Dr. Trevor Royce: So much fun though. It still hurts.
Dr. Tim Showalter: It was fun. And Paul and I had the opportunity to get a lot of interviews done there. Lots of great conversations. Ones that really stuck with me in particular that I'm thinking of today are the Remedy CEO, [Could not verify with context], on building health technology in a way that's for healthcare providers directly. And the problem they're specifically taking on is remote patient monitoring. But she's a physician, CEO, and has a great backstory for how that company came to be.
And then the other one is Dr. Kim Boyd from Weight Watchers. To me, I'm really curious to see what happens in 2026 and beyond with that company. She's got real bona fides from the health technology space. I recall she was doing telemedicine since 2011, so she's OG for this, well before the pandemic. Of course, Weight Watchers doesn't hold the cultural cachet that it used to, but they did acquire a telemedicine company in 2023 and have recasted their services with lifestyle interventions mixed with remote dietary services and even GLP-1 prescriptions. And I think they're really moving towards overall metabolic health support. I think that'll be a really interesting company to watch.
Dr. Paul Gerrard: I had the interview with [Could not verify with context] from GE Healthcare. And he really talked about the new direction that GE Healthcare is going. He leads the—he's the global head of healthcare pathways at GE Healthcare. And he really talked about the fact that GE has traditionally been considered this company that makes the devices in the boxes, the machines you see in the hospitals, but they're really thinking about their future of how they can integrate better into healthcare pathways.
And so they're trying to think more about software and more about the holistic technology, end-to-end healthcare system with their device being one piece of that solution. And he really talked about this three-legged stool for AI adoption, which is clinical benefits, IT simplicity, and strong ROI, as well as patient-centric healthcare pathways. Maybe I'm just behind the times on thinking about how to think about GE, but it sounds like GE is really about transforming itself from being the device company to the healthcare pathway company for the future.
Rethinking Human Performance: The Provocative Case of the Enhanced Games
Dr. Tim Showalter: Awesome. We've published 34 episodes in 2025 and we've spent, I don't know how many hours together, including on vacations and whatnot, recording this. For me, it's been a huge, wonderful project to spend time with you guys. I feel we've learned a lot and it's been great to share this with everyone.
I wanted to give one reflection on the podcast that I share with people. When they ask what would be a good one to listen to, I often come back to the Enhanced Games podcast. We haven't talked about that. It will be interesting to see what the updates are next year and beyond for that. But I think that was the most surprising and wide-ranging conversation I think we had this year and gave me the most reason to question my thoughts before I came to the conversation. It really made me reconsider how I've categorized that whole human performance medicine and to think through it quite differently. And it's obviously a pretty controversial topic, but that's one that was an interesting conversation to share with you guys.
Dr. Paul Gerrard: I thought that was a really interesting one. On the surface, it sticks out because it sounds like you're thinking about sports and how that tethers to health technology. But I think the other way that is really different is, a lot of these companies we have talked with are thinking about where healthcare is today. They're saying, 'Here healthcare is today. What's that next little tiny incremental step I can do to make things better?' And that's really important.
But Enhanced, these guys are talking about the future of humanity. They're not looking at what's the next little step in front of us. They're saying, 'We fundamentally, we don't want to make you a little better at the game. We fundamentally want to change the game,' both literally and figuratively. People may agree or disagree on whether the way they want to do it is good or bad, but I think it's really interesting that they truly are trying to take a visionary approach.
Dr. Trevor Royce: I am so glad you guys mentioned Enhanced Games. What a fun episode, and something that before we started out on this podcast journey, I don't know that I ever would have expected spending that much time thinking or learning about this. And wow, it changed the way that I started thinking about society in some ways. As a big sports fan, obviously you can't help but think about how this would be different if everything was legal. And that was a very provocative episode. A ton of fun with you guys.
Dr. Tim Showalter: Well, I think we've got time for one more round. Trevor, any other suggestions for what we should cover before we close out?
Final Reflections on the Podcast Journey
Dr. Trevor Royce: I'm going to share, I guess, some personal reflections on this experience with you guys. A core theme of all this is obviously the human element. And just a huge thank you to all the guests that we had that took their time and energy out of their very busy entrepreneurial lives to come on and spend time with us. Their stories were so inspiring. There are so many folks that we haven't had a chance to mention because we can't go through all of them. But, Gaurav Singal, Meg Powell, Michele Colucci, all these people had incredible careers that they shared with us.
And it gets to this idea of accountability. One of my favorite tech entrepreneurs is Naval Ravikant, who's written a lot of books about his life as an entrepreneur and is inspiring. One thing he talks about a lot is accountability. And this podcast embraces that idea of accountability, where you put something together, your thoughts, and you put it out there to the world. And you don't know if anyone's going to like it or listen to it. But once you commit to publishing that and putting it out there, then you own it. And so you take pride in that and you think about it. And it's a lot of fun to do that. And that's part of the satisfaction of life related to that.
Michele Colucci, 5.6 thousand views on YouTube. That's our top episode. The Viz AI episode, 4.7 thousand views. Amy Abernathy, 3.7 thousand views. Those are just our top three episodes, at least on YouTube, out of all of our episodes this year. That's pretty cool for us to look back at that and think that people are actually listening to what we have to say and probably more importantly, what our guests had to say. It's been a fun ride with you guys.
Dr. Tim Showalter: In 2026, I think we've got a lot in store. We've got some big episodes lined up that we've already started recording for. And I think it'll be interesting to see what the themes are that emerge next year as well. I think we all agree that we're going to release an episode every two weeks instead of weekly as we go into 2026, but that'll give us more time to make sure that we've got the best guests and companies available. Well, Trevor, do you want to read us out?
Dr. Trevor Royce: All right, guys. Well, that's our holiday special. It's been a lot of fun. Paul and Tim, thanks for taking the time out of the busy holiday schedule to record this. And to our listeners, thanks for being a part of the Health Tech Remedy community. Looking forward to seeing you in 2026. It's going to be a great year. Thanks for joining us.
